Utility of Host Markers Detected in Quantiferon Supernatants for the Diagnosis of Tuberculosis in Children in a High-Burden Setting

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Chegou, Novel N ^a   Detjen, Anne K ^a,b   Thiart, Lani ^a   Walters, Elisabetta ^a   Mandalakas, Anna M ^c   Hesseling, Anneke C ^a   Walzl, Gerhard ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; BIOLOGICAL MARKER; CD40 LIGAND; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; VASCULOTROPIN;

ANALYTICAL EQUIPMENT; ARTICLE; BACTERIUM CULTURE; BLOOD ANALYSIS; CHILD; CHILD HEALTH CARE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INCUBATION TIME; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRESCHOOL CHILD; PROTEIN ANALYSIS; SERODIAGNOSIS; SUPERNATANT; TUBERCULOSIS; VALIDATION PROCESS;

BIOLOGICAL MARKERS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; SOUTH AFRICA; TUBERCULOSIS;

EID: 84877732147     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064226     Document Type: Article

References (60)

1. Zar HJ, Hanslo D, Apolles P, Swingler G, Hussey G, (2005) Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 365: 130-134.
2. WHO (2011) Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System Policy Statement.
3. Nicol MP, Workman L, Isaacs W, Munro J, Black F, et al. (2011) Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 11: 819-824.
4. Trebucq A, Enarson DA, Chiang CY, Van DA, Harries AD, et al. (2011) Xpert((R)) MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how? Int J Tuberc Lung Dis 15: 1567-1572.
5. Marais BJ, Hesseling AC, Gie RP, Schaaf HS, Enarson DA, et al. (2006) The bacteriologic yield in children with intrathoracic tuberculosis. Clin Infect Dis 42: e69-e71.
6. Marais BJ, Rabie H, Cotton MF, (2011) TB and HIV in children- advances in prevention and management. Paediatr Respir Rev 12: 39-45.
7. Hesseling AC, Mandalakas AM, Kirchner HL, Chegou NN, Marais BJ, et al. (2009) Highly discordant T cell responses in individuals with recent exposure to household tuberculosis. Thorax 64: 840-846.
8. Mandalakas AM, Hesseling AC, Chegou NN, Kirchner HL, Zhu X, et al. (2008) High level of discordant IGRA results in HIV-infected adults and children. Int J Tuberc Lung Dis 12: 417-423.
9. Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, et al. (2011) Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 37: 88-99.
10. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D, (2011) Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 15: 1018-1032.
11. World Health Organization and the International Union Against Tuberculosis and Lung Disease (2010) Guidance for national tuberculosis and HIV programmes on the management of tuberculosis in HIV-infected children: Recommendations for a public health approach.
12. Ahmed RK, Rohava Z, Balaji KN, Hoffner SE, Gaines H, et al. (2012) Pattern recognition and cellular immune responses to novel Mycobacterium tuberculosis-antigens in individuals from Belarus. BMC Infect Dis 12: 41.
13. Chegou NN, Black GF, Loxton AG, Stanley K, Essone PN, et al. (2012) Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting. BMC Infect Dis 12: 10.
14. Goletti D, Raja A, Syed Ahamed KB, Rodrigues C, Sodha A, et al. (2010) Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS ONE 5: e12577.
15. Sartain MJ, Slayden RA, Singh KK, Laal S, Belisle JT, (2006) Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling. Mol Cell Proteomics 5: 2102-2113.
16. Lu C, Wu J, Wang H, Wang S, Diao N, et al. (2011) Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells. PLoS ONE 6: e24290.
17. Frahm M, Goswami ND, Owzar K, Hecker E, Mosher A, et al. (2011) Discriminating between latent and active tuberculosis with multiple biomarker responses. Tuberculosis (Edinb) 91: 250-256.
18. Kellar KL, Gehrke J, Weis SE, Mahmutovic-Mayhew A, Davila B, et al. (2011) Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS ONE 6: e26545.
19. Sutherland JS, de Jong BC, Jeffries DJ, Adetifa IM, Ota MO, (2010) Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort. PLoS ONE 5: e12365.
20. Chegou NN, Black GF, Kidd M, van Helden PD, Walzl G, (2009) Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report. BMC Pulm Med 9: 21.
21. Ruhwald M, Bjerregaard-Andersen M, Rabna P, Kofoed K, Eugen-Olsen J, et al. (2007) CXCL10/IP-10 release is induced by incubation of whole blood from tuberculosis patients with ESAT-6, CFP10 and TB7.7. Microbes Infect 9: 806-812.
22. Ruhwald M, Petersen J, Kofoed K, Nakoaka H, Cuevas LE, et al. (2008) Improving T-Cell Assays for the Diagnosis of Latent TB Infection: Potential of a diagnostic Test Based on IP-10. Plos One 3: e2858.
23. Ruhwald M, Bodmer T, Maier C, Jepsen M, Haaland MB, et al. (2008) Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis. Eur Respir J 32: 1607-1615.
24. Tanaka T, Sakurada S, Kano K, Takahashi E, Yasuda K, et al. (2011) Identification of tuberculosis-associated proteins in whole blood supernatant. BMC Infect Dis 11: 71.
25. Rubbo PA, Nagot N, Le Moing V, Brabet M, Bourdin A et al. (2012) Multi-cytokine detection improves latent tuberculosis diagnosis in healthcare workers. J Clin Microbiol. In press.
26. Jones GJ, Pirson C, Hewinson RG, Vordermeier HM, (2010) Simultaneous measurement of antigen-stimulated interleukin-1 beta and gamma interferon production enhances test sensitivity for the detection of Mycobacterium bovis infection in cattle. Clin Vaccine Immunol 17: 1946-1951.
27. Whittaker E, Gordon A, Kampmann B, (2008) Is IP-10 a better biomarker for active and latent tuberculosis in children than IFNgamma? PLoS ONE 3: e3901.
28. Harari A, Rozot V, Enders FB, Perreau M, Stalder JM, et al. (2011) Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med 17: 372-376.
29. Webb EA, Hesseling AC, Schaaf HS, Gie RP, Lombard CJ, et al. (2009) High prevalence of Mycobacterium tuberculosis infection and disease in children and adolescents with type 1 diabetes mellitus. Int J Tuberc Lung Dis 13: 868-874.
30. Marais BJ, Gie RP, Schaaf HS, Starke JR, Hesseling AC, et al. (2004) A proposed radiological classification of childhood intra-thoracic tuberculosis. Pediatr Radiol 34: 886-894.
31. Graham SM, Ahmed T, Amanullah F, Browning R, Cardenas V, et al. (2012) Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis 205Suppl 2: S199-S208.
32. Detjen AK, Loebenberg L, Grewal HM, Stanley K, Gutschmidt A, et al. (2009) Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol 16: 1170-1175.
33. Chegou NN, Essone PN, Loxton AG, Stanley K, Black GF, et al. (2012) Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area. PLoS ONE 7: e38501.
34. Schoenborn JR, Wilson CB, (2007) Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 96: 41-101.
35. van IJ, de ZR, Dekhuijzen R, Boeree M, van SD, (2009) Region of difference 1 in nontuberculous Mycobacterium species adds a phylogenetic and taxonomical character. J Bacteriol 191: 5865-5867.
36. Prabhakar S, Qiao Y, Hoshino Y, Weiden M, Canova A, et al. (2003) Inhibition of response to alpha interferon by Mycobacterium tuberculosis. Infect Immun 71: 2487-2497.
37. Mariotti S, Teloni R, Iona E, Fattorini L, Romagnoli G, et al. (2004) Mycobacterium tuberculosis diverts alpha interferon-induced monocyte differentiation from dendritic cells into immunoprivileged macrophage-like host cells. Infect Immun 72: 4385-4392.
38. Dufour JH, Dziejman M, Liu MT, Leung JH, Lane TE, et al. (2002) IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J Immunol 168: 3195-3204.
39. Juffermans NP, Verbon A, van Deventer SJ, van DH, Speelman P, et al. (1998) Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis. Am J Respir Crit Care Med 157: 1328-1331.
40. Arend WP, (2002) The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 13: 323-340.
41. Perrier S, Darakhshan F, Hajduch E, (2006) IL-1 receptor antagonist in metabolic diseases: Dr Jekyll or Mr Hyde? FEBS Lett 580: 6289-6294.
42. Bermudez LE, Petrofsky M, Shelton K, (1996) Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection. Infect Immun 64: 2917-2922.
43. Parker AE, Bermudez LE, (2000) Sequence and characterization of the glyceraldehyde-3-phosphate dehydrogenase of Mycobacterium avium: correlation with an epidermal growth factor binding protein. Microb Pathog 28: 135-144.
44. Husain N, Awasthi S, Haris M, Gupta RK, Husain M, (2008) Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis. J Infect 56: 114-119.
45. Kiropoulos TS, Kostikas K, Gourgoulianis KI, (2005) Vascular endothelial growth factor levels in pleural fluid and serum of patients with tuberculous pleural effusions. Chest 128: 468-469.
46. Alatas F, Alatas O, Metintas M, Ozarslan A, Erginel S, et al. (2004) Vascular endothelial growth factor levels in active pulmonary tuberculosis. Chest 125: 2156-2159.
47. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ, (1998) T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393: 480-483.
48. Mizusawa M, Kawamura M, Takamori M, Kashiyama T, Fujita A, et al. (2008) Increased synthesis of anti-tuberculous glycolipid immunoglobulin G (IgG) and IgA with cavity formation in patients with pulmonary tuberculosis. Clin Vaccine Immunol 15: 544-548.
49. Sakai H, Okafuji I, Nishikomori R, Abe J, Izawa K, et al. (2012) The CD40-CD40L axis and IFN-gamma play critical roles in Langhans giant cell formation. Int Immunol 24: 5-15.
50. Ruhwald M, Aabye MG, Ravn P, (2012) IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn 12: 175-187.
51. Alsleben N, Ruhwald M, Russmann H, Marx FM, Wahn U, et al. (2012) Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study. Scand J Infect Dis 44: 256-262.
52. Lighter-Fisher J, Peng CH, Tse DB, (2010) Cytokine responses to QuantiFERON(R) peptides, purified protein derivative and recombinant ESAT-6 in children with tuberculosis. Int J Tuberc Lung Dis 14: 1548-1555.
53. Kabeer BS, Sikhamani R, Raja A, (2010) Comparison of interferon gamma and interferon gamma-inducible protein-10 secretion in HIV-tuberculosis patients. AIDS 24: 323-325.
54. World Health Organisation (2011) Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle-income countries: policy statement.
55. Syed Ahamed KB, Sikhamani R, Swaminathan S, Perumal V, Paramasivam P, et al. (2009) Role of interferon gamma release assay in active TB diagnosis among HIV infected individuals. PLoS ONE 4: e5718.
56. Syed Ahamed KB, Raman B, Thomas A, Perumal V, Raja A, (2010) Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS ONE 5: e9051.
57. Wang S, Diao N, Lu C, Wu J, Gao Y, et al. (2012) Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated population. PLoS ONE 7: e51338.
58. Goin JE, (1982) ROC curve estimation and hypothesis testing: applications to breast cancer detection. Pattern Recognition 15: 263-269.
59. Su WL, Perng WC, Huang CH, Yang CY, Wu CP, et al. (2010) Identification of cytokines in whole blood for differential diagnosis of tuberculosis versus pneumonia. Clin Vaccine Immunol 17: 771-777.
60. Desem N, Jones SL, (1998) Development of a human gamma interferon enzyme immunoassay and comparison with tuberculin skin testing for detection of Mycobacterium tuberculosis infection. Clin Diagn Lab Immunol 5: 531-536.